Tempsens Instruments’ and Gaja Capital’s initial public offerings (IPOs) are attracting investor attention as media reports compare their latest grey-market premium (GMP) figures and the listing gains implied by those prices. Coverage frames the comparison around current GMP trends and what they could mean for how the stocks might trade on listing.
The outlets discuss IPO fundamentals alongside market signals. Reports include issue-related details such as the offering structure and subscription status, aiming to show how investor demand aligns—or does not—with GMP movements. The core angle across the coverage is that the two IPOs are being evaluated side by side, with investors focusing on both demand indicators and the gap between the IPO price and the estimated market price suggested by GMP.
While specific numbers may vary by update and timing, the overall theme is consistent: both companies’ IPOs remain under active scrutiny in the lead-up to listing, with different emphasis on short-term GMP expectations versus longer-term issue particulars such as subscription trends.
